Treatment of recurrent refractory mantle cell lymphoma by thalidomide in combination with interferon

Full Length Research Paper

Lijie Han
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Huifang Zhao
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Qingsong Yin
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Lin Chen
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Yongping Song
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Xudong Wei*
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Search for this author on:
Google Scholar

Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

Authors

Lijie Han
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Huifang Zhao
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Qingsong Yin
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Lin Chen
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Yongping Song
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Xudong Wei*
Department of Hematology Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Corresponding Author Email: [email protected]

This article is published under the terms of the Creative Commons Attribution License 4.0

Views: 0
Downloads: 0